Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Globus Medical A | 1 | 0 | 0 | 0 | €63.00 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.46 | - | - |
| GSK plc ADR | 5 | 0 | 0 | 0 | €39.80 | €49.33 | 23.937% |
| Halozyme Therapeutics Inc. | 22 | 0 | 1 | 0 | €53.48 | €57.30 | 7.146% |
| HCA Holdings Inc. | 42 | 0 | 4 | 0 | €350.70 | €353.98 | 0.934% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| Henry Schein Inc. | 15 | 1 | 1 | 0 | €62.42 | €76.08 | 21.883% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €1.66 | €4.63 | 178.663% |
| Hologic Inc. | 19 | 0 | 1 | 0 | €75.00 | €83.38 | 11.168% |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |
| Humana Inc. | 24 | 0 | 1 | 0 | €310.00 | €381.08 | 22.927% |
| Hutchison China MediTech Ltd ADR | 3 | 0 | 0 | 0 | €14.80 | €20.23 | 36.691% |
| Icon plc | 24 | 0 | 0 | 0 | €255.60 | €324.79 | 27.069% |
| Icu Medical Inc. | 6 | 0 | 0 | 0 | €148.00 | €139.70 | -5.610% |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | €442.80 | €554.23 | 25.165% |
| Illumina Inc. | 32 | 4 | 6 | 0 | €112.02 | €160.20 | 43.012% |
| Immunic Inc. | 7 | 3 | 3 | 0 | €1.25 | €6.43 | 414.229% |
| Immunogen Inc. | 2 | 0 | 0 | 0 | €28.97 | - | - |
| Incyte Corp. | 13 | 2 | 0 | 0 | €56.06 | €77.67 | 38.550% |
| Innoviva Inc. | 6 | 0 | 0 | 0 | €17.30 | €30.00 | 73.410% |
| Inogen Inc. | 1 | 2 | 0 | 0 | €10.20 | €6.53 | -35.936% |
| Insmed Inc. | 46 | 0 | 5 | 0 | €65.00 | €77.15 | 18.692% |
| Insulet Corp. | 17 | 0 | 1 | 0 | €205.20 | €216.46 | 5.488% |
| Integer Hldg | 1 | 0 | 0 | 0 | €115.00 | - | - |
| Intra-Cellular Therapies Inc. | 32 | 0 | 2 | 0 | €67.50 | €84.46 | 25.120% |